Iterum Therapeutics Plc

NASDAQ:ITRM  
0.26
0.00 (+0.85%)
Earnings Announcements

Iterum Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/13/2022 11:39 GMT
Iterum Therapeutics Plc (ITRM) - Iterum Therapeutics Reports First Quarter 2022 Financial Results.
Iterum Therapeutics Plc - Qtrly Net Loss per Share $0.02.
Iterum Therapeutics Plc - Qtrly Non-GAAP Net Loss per Share $0.03.
Iterum Therapeutics - Based on Current Operating Plan, Expects Current Cash, Short-term Investments Will Be Sufficient to Fund Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.